semaglutide during covid reduced mortality in obese patients by lowering infection-related deaths COVID-19 pandemic Semaglutide: The benefits and risks

Nausea, constipation, and diarrhea are most frequent, occurring mainly during dose escalation

Mantripragada KK, Spurlock G, Kluwe L, Chuzhanova N, Ferner RE, Frayling IM, et al

Shima Hadidchi, MD, we emphasize a holistic approach to health and wellness, including effective strategies to reduce belly fat and improve overall well-being

growth hormone secretagogues to stimulate natural growth hormone production) or exogenous (ex

(2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) This article was reviewed and approved by Lujain Alhassan, Bariatric Nutritionist, on 31 October 2025

Collectively, these molecular modifications engender a self-reinforcing cycle of mitochondrial dysfunction, oxidative damage, and inflammation that expedites the deterioration of both muscular and vascular systems